ATE534618T1 - Neues verfahren zur herstellung therapeutischer verbindungen und zusammensetzungen, dadurch hergestellte verbindungen und zusammensetzungen und deren verwendung - Google Patents

Neues verfahren zur herstellung therapeutischer verbindungen und zusammensetzungen, dadurch hergestellte verbindungen und zusammensetzungen und deren verwendung

Info

Publication number
ATE534618T1
ATE534618T1 AT07716121T AT07716121T ATE534618T1 AT E534618 T1 ATE534618 T1 AT E534618T1 AT 07716121 T AT07716121 T AT 07716121T AT 07716121 T AT07716121 T AT 07716121T AT E534618 T1 ATE534618 T1 AT E534618T1
Authority
AT
Austria
Prior art keywords
compositions
compounds
new method
produced therefrom
nitrites
Prior art date
Application number
AT07716121T
Other languages
English (en)
Inventor
Lars E Gustafsson
Dag Linnarsson
Kristofer Nilsson
Original Assignee
Lars E Gustafsson
Dag Linnarsson
Kristofer Nilsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lars E Gustafsson, Dag Linnarsson, Kristofer Nilsson filed Critical Lars E Gustafsson
Application granted granted Critical
Publication of ATE534618T1 publication Critical patent/ATE534618T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/04—Preparation of esters of nitrous acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C07B43/02—Formation or introduction of functional groups containing nitrogen of nitro or nitroso groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
AT07716121T 2006-03-14 2007-03-14 Neues verfahren zur herstellung therapeutischer verbindungen und zusammensetzungen, dadurch hergestellte verbindungen und zusammensetzungen und deren verwendung ATE534618T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0600566 2006-03-14
PCT/SE2007/050152 WO2007106034A1 (en) 2006-03-14 2007-03-14 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use

Publications (1)

Publication Number Publication Date
ATE534618T1 true ATE534618T1 (de) 2011-12-15

Family

ID=38509772

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07716121T ATE534618T1 (de) 2006-03-14 2007-03-14 Neues verfahren zur herstellung therapeutischer verbindungen und zusammensetzungen, dadurch hergestellte verbindungen und zusammensetzungen und deren verwendung

Country Status (8)

Country Link
US (1) US8030511B2 (de)
EP (1) EP2004576B1 (de)
JP (1) JP5191477B2 (de)
CN (1) CN101443292B (de)
AT (1) ATE534618T1 (de)
AU (1) AU2007225489A1 (de)
DK (1) DK2004576T3 (de)
WO (1) WO2007106034A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2830298C (en) 2011-03-17 2016-08-16 Transdermal Biotechnology, Inc. Topical nitric oxide systems comprising lecithin and methods of use thereof
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
GB2579240B (en) 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
GB202007928D0 (en) * 2020-05-27 2020-07-08 Attgeno Ab New uses and methods
GB202007929D0 (en) 2020-05-27 2020-07-08 Attgeno Ab New medical uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2144420C3 (de) 1971-09-04 1978-11-23 Basf Ag, 6700 Ludwigshafen Salpetrigsäureester von Glykolen und Glykolderivaten, deren Herstellung und Verwendung
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US6087479A (en) * 1993-09-17 2000-07-11 Nitromed, Inc. Localized use of nitric oxide-adducts to prevent internal tissue damage
SG71167A1 (en) * 1997-10-21 2000-03-21 Ube Industries Process for producing alkyl nitrite
EP1877374A1 (de) * 2005-03-18 2008-01-16 Nitromed, Inc. Organische stickoxidverstärkende salze von inhibitoren des angiotensin converting enzyme, zusammensetzungen und anwendungsverfahren

Also Published As

Publication number Publication date
US20090258944A1 (en) 2009-10-15
DK2004576T3 (da) 2012-03-05
EP2004576B1 (de) 2011-11-23
JP5191477B2 (ja) 2013-05-08
US8030511B2 (en) 2011-10-04
AU2007225489A1 (en) 2007-09-20
EP2004576A1 (de) 2008-12-24
WO2007106034A1 (en) 2007-09-20
EP2004576A4 (de) 2009-12-02
CN101443292B (zh) 2012-07-18
CN101443292A (zh) 2009-05-27
JP2009534298A (ja) 2009-09-24

Similar Documents

Publication Publication Date Title
ATE534618T1 (de) Neues verfahren zur herstellung therapeutischer verbindungen und zusammensetzungen, dadurch hergestellte verbindungen und zusammensetzungen und deren verwendung
MX2009012183A (es) Moleculas depuradoras del oxigeno, articulos que contienen las mismas y sus metodos de uso.
ATE458535T1 (de) Verfahren zur herstellung von konzentrierten tensidzusammensetzungen
DE502006008395D1 (de) Verfahren zur herstellung von metallorganischen gerüstmaterialien hauptgruppen metallionen enthaltend
ATE475655T1 (de) Verfahren zur herstellung von (s)-4- fluormethyldihydrofuran-2-on
ATE520427T1 (de) Poröse intravaskuläre embolisierungsteilchen und verfahren zu deren herstellung
AT507172A3 (de) Verfahren zur herstellung von dibenz (c,e) (1,2)- oxaphosphorin-derivaten, amino-dibenz (c,e) (1,2)-oxaphosphorin sowie deren verwendung
BRPI0613543B8 (pt) Método para produção de 1,3-propanodiol usando glicerol bruto, um subproduto da produção de biodiesel
WO2010088001A3 (en) Sequestration of compounds from microorganisms
EA201101695A1 (ru) Усовершенствованный способ синтеза пирфенидона
TW200630359A (en) (S)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4-homopiperazine hydrochloride dihydrate
ATE463541T1 (de) Verdickungssysteme und wässrige beschichtingszusammensetzungen und verfahren zu deren herstellung und verwendung
DE502005010342D1 (en) Substituierte cyclohexylessigsäure-derivate
WO2008088039A1 (ja) ドネペジルを含有する安定化医薬組成物、その製造方法、及び安定化方法
WO2011060297A3 (en) Oxygen scavengers, composition comprising the scavengers, and articles made from the compositions
DE602007008514D1 (de) Elektrode zur Wasserstofferzeugung und Verfahren zu deren Herstellung
SI2021002T1 (sl) Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
MX2009005581A (es) Particulas estables de lactido.
ATE368091T1 (de) Elektrolumineszenz-vorrichtung sowie verfahren zu ihrer herstellung
ATE533474T1 (de) Durch nassgranulation hergestellte stabile und fertig gelöste zusammensetzungen aus candesartan- cilexetil
MX2009005423A (es) Nuevo procedimiento para la preparacion de 4,4'-(1-metil-1,2-etand il)-bis-(2,6-piperazindiona).
ATE510812T1 (de) Verfahren zur reinigung von cyclischen ketonen
UY30673A1 (es) Derivados 6, 7 y 8 sustituidos del acido (3r)-5-oxo-2,3-dihidro-5h-tiazolo[3,2a]piridin-3-carboxilico, composiciones farmacéuticas conteniéndolos y aplicaciones.
GB2450040A (en) Novel crystallization methods and novel crystalline and amorphous forms of halo-genated sugars
ATE460979T1 (de) Verfahren zur herstellung von nanoskaligen pulvern